跳至主要内容
临床试验/NCT01280006
NCT01280006已完成1 期

Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans

University of Calgary2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2011年1月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Arterial Blood Pressure

研究概览

简要总结

The study has been designed to assess the effect of cyclooxygenase inhibition on blood pressure, cerebral blood flow, ventilation and renal hemodynamics following chronic intermittent hypoxia exposure.

详细描述

The study will specifically evaluate:

  1. Cardiovascular effect of cyclooxygenase inhibitors on cerebral, vascular, blood pressure and homeostatic responses following chronic intermittent hypoxia exposure.
  2. Ventilatory response of cyclooxygenase inhibitors following chronic intermittent hypoxia exposure
  3. Evaluate the renal hemodynamic effect of chronic intermittent hypoxia exposure and cyclooxygenase inhibition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects
  • 18 - 45 years of age
  • Informed written consent

排除标准

  • Any history of cardio-respiratory diseases, ongoing medication, smoking, trauma, acute illnesses, collagen vascular diseases, rheumatoid arthritis, osteoarthritis

结局指标

主要结局

Arterial Blood Pressure

时间窗: Six weeks

Blood pressure will be monitored during all three protocols.

Cerebral Blood Flow

时间窗: Six weeks

The cerebral blood flow will be mesauresed during each testing days of all three protocols.

次要结局

  • Ventilatory Response(Six weeks.)
  • Renal Hemodynamics(Six weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marc Poulin

Prof Dr.

University of Calgary

研究点 (2)

Loading locations...

相似试验